Golden has been acquired by ComplyAdvantage.Read about it here ⟶

Five Prime Therapeutics

Five Prime Therapeutics is a biotechnology company focused on the discovery and development of protein therapeutics, it was acquired by Amgen in 2021.

Overview Structured Data Issues Contributors Activity

fiveprime.com

Is a

Company

Organization

Company attributes

Industry

Biopharmaceutical

Healthcare

Diagnosis

Pharmaceutical industry

Consumer biotechnology

Technology

...

Location

South San Francisco, California

Thousand Oaks, California

San Francisco

AngelList URL

angel.co/five-prime...herapeutics

Pitchbook URL

pitchbook.com/profiles.../50945-05

Phone Number

+180544710000

Full Address

One Amgen Center Drive Thousand Oaks, CA0

Investors

Lightstone Ventures

Wellcome Trust

Kleiner Perkins Caufield & Byers

TPG Growth

Brian Atwood

Advanced Technology Ventures

HealthCap

Domain Associates

...

Founded Date

2001

Total Funding Amount (USD)

55,000,000

Latest Funding Round Date

April 20, 2012

Also Known As

Amgen0

Five Prime Therapeutics, Inc.

Patents Assigned (Count)

Wellfound ID

five-prime-therapeutics

Country

United States

Other attributes

Company Operating Status

Active

No article content yet.

Timeline

No Timeline data yet.

Funding Rounds

Products

Acquisitions

SBIR/STTR Awards

Patents

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more companies like Five Prime Therapeutics

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.

Open Query Tool

Access by API